Coronary intervention for persistent occlusion after myocardial infarction
about
Analysis of arterial intimal hyperplasia: review and hypothesisManagement of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimatesNext-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V)Advances in stress cardiac MRI and computed tomography.Safety and efficacy of bone marrow-derived autologous CD133+ stem cell therapy.Loss of short-term symptomatic benefit in patients with an occluded infarct artery is unrelated to non-protocol revascularization: results from the Occluded Artery Trial (OAT).Renal impairment and heart failure with preserved ejection fraction early post-myocardial infarctionImproved clinical outcome after invasive management of patients with recent myocardial infarction and proven myocardial viability: primary results of a randomized controlled trial (VIAMI-trial).Risk and treatment effect heterogeneity: re-analysis of individual participant data from 32 large clinical trials.Angiographic and clinical outcomes of drug-eluting versus bare metal stent deployment in the Occluded Artery Trial.Percutaneous coronary intervention in the Occluded Artery Trial: procedural success, hazard, and outcomes over 5 years.Distribution and determinants of myocardial perfusion grade following late mechanical recanalization of occluded infarct-related arteries postmyocardial infarction: a report from the occluded artery trial.Thymosin β4 promotes the survival and angiogenesis of transplanted endothelial progenitor cells in the infarcted myocardium.Impact of left ventricular ejection fraction on clinical outcomes over five years after infarct-related coronary artery recanalization (from the Occluded Artery Trial [OAT]).Current Status of Coronary Intervention in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery DiseaseEffects of timing, location and definition of reinfarction on mortality in patients with totally occluded infarct related arteries late after myocardial infarction.Causes of death in early MI survivors with persistent infarct artery occlusion: results from the Occluded Artery Trial (OAT).Impact of collateral flow to the occluded infarct-related artery on clinical outcomes in patients with recent myocardial infarction: a report from the randomized occluded artery trialLeft ventricular remodeling after late revascularization correlates with baseline viability.Reinfarction after percutaneous coronary intervention or medical management using the universal definition in patients with total occlusion after myocardial infarction: results from long-term follow-up of the Occluded Artery Trial (OAT) cohort.Effectiveness of percutaneous coronary intervention within 12 hours to 28 days of ST-elevation myocardial infarction in a real-world Chinese population.The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy aloneImpact of percutaneous coronary intervention on biomarker levels in patients in the subacute phase following myocardial infarction: the Occluded Artery Trial (OAT) biomarker ancillary studyType-II myocardial infarction--patient characteristics, management and outcomes.Long-term effects of percutaneous coronary intervention of the totally occluded infarct-related artery in the subacute phase after myocardial infarction.Advancing cardiovascular research.The importance of cardiac biomarkers on remodelling after myocardial infarctionComparison of late results of percutaneous coronary intervention among stable patients ≤65 versus >65 years of age with an occluded infarct related artery (from the Occluded Artery Trial)Isolated right ventricular infarction after modified Cabrol operation.Perspectives on the management of coronary artery disease in India.Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.Multimodality imaging evaluation of functional and clinical benefits of percutaneous coronary intervention in patients with chronic total occlusion lesion.Effect of late revascularization of a totally occluded coronary artery after myocardial infarction on mortality rates in patients with renal impairment.Abrupt progression of ventricular septal perforation after primary angioplasty for acute myocardial infarction.Impact of Admission Glycosylated Hemoglobin A1c on Angiographic Characteristics and Short Term Clinical Outcomes of Nondiabetic Patients with Acute ST-Segment Elevation Myocardial Infarction.Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT)Comparison of the myocardial clearance of endothelial progenitor cells injected early versus late into reperfused or sustained occlusion myocardial infarction.Infarct artery distribution and clinical outcomes in occluded artery trial subjects presenting with non-ST-segment elevation myocardial infarction (from the long-term follow-up of Occluded Artery Trial [OAT]).New percutaneous approaches for chronic total occlusion of coronary arteries.
P2860
Q21245222-77AAB915-EC35-4662-95EE-601B9A6028D6Q22242896-227131D4-2156-42BD-9165-D39A9C16D215Q24186056-E8B6523C-AD50-4D97-B12D-DFC876E8226DQ24642679-1E7C8845-7B95-4154-AD1E-9EFBB1ED8776Q30412128-B7AC00D2-C164-4C03-AAE8-E13688609CE8Q30428262-78652A73-8516-4028-89D3-AD992CF8200CQ30429019-52101FBC-2EA9-44FB-8BE5-B1829B0629D5Q30434062-E7C05649-F15C-4511-9CFD-F154215697BDQ30471377-9010F445-6F13-4BE0-ACF3-E890C34CD82BQ31112168-9DDAE4B2-FA8F-404F-9C26-EAF95480B3D6Q33642414-041ACC13-A94B-4233-A711-9175B87D624AQ33646291-E429A63C-13BF-40BD-92CE-13CF32824F16Q33648768-612268C1-F75B-43CF-AFAA-342742A82B11Q33674848-596533DA-5E0E-4EEF-BE8F-7EB6695BEB90Q33675490-D7447A27-88D4-43C4-8D22-BB12D8AE8A0DQ33681926-6B8B90E1-B34A-4BA2-85E5-6DF5075AE4E3Q33792693-6F129C67-4804-42DB-86C8-DD0D7E4D05C8Q33946772-B2F873C9-3F07-4386-B36A-2456AC18ACF1Q33978681-6282B54B-97D4-4E40-9F97-5BD295FF6BD3Q33996791-085EA1BA-41FB-4AB5-BC09-E0F2C529C3A1Q34549223-FBE13B9E-D418-4E34-BD46-11090D29DF85Q34648000-EB3A9B9D-C6BD-4ECF-A833-7ABB53EB00C4Q34778284-1E504120-9316-441E-ACC7-91D95C2D07F3Q35025805-CB550BAC-D8FB-4FB8-AD42-53C810FDEE99Q35083354-06FF7E50-FBDD-4A56-A7B0-7A686316B534Q35607236-B9DC69AF-8D5C-4D21-AFD6-1748E7E3BBC2Q35750181-B0395A37-4C24-40F7-A761-1648BC107DA2Q35757014-F57B6CDF-0E83-48BE-8241-4EDB33449455Q35784799-47D053E6-592D-43BF-8B99-9D4308D1A67FQ35820101-4B8EBFFC-A149-4AE3-9EE8-580F0BB49E26Q36057242-70CAE9FC-2DA3-4F83-8B3F-C4571652F083Q36157290-73BEDECA-3D2A-4DC2-B09A-623B142B2BBAQ36181676-2BD244EC-EBF6-4F3F-B643-BEEDD9B381C5Q36227525-9AEA60C1-7121-4842-8BE5-E0D0F9022867Q36338374-27A6885B-1A72-4CBC-A8FB-61CADD3FFF8BQ36368989-B3FF43FF-0A34-4A53-8CBA-BC17BCE42170Q36455475-CC6038A7-F9DA-4688-836F-6D4BD8F6035DQ36578130-E5732E6C-9986-4BC7-AAC6-B790E4E18CF6Q36747252-4B33EAAB-3B00-440A-A965-F56475AF4A7FQ36752088-F6548275-E77A-486C-8E43-3E619B61E294
P2860
Coronary intervention for persistent occlusion after myocardial infarction
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Coronary intervention for persistent occlusion after myocardial infarction
@ast
Coronary intervention for persistent occlusion after myocardial infarction
@en
type
label
Coronary intervention for persistent occlusion after myocardial infarction
@ast
Coronary intervention for persistent occlusion after myocardial infarction
@en
prefLabel
Coronary intervention for persistent occlusion after myocardial infarction
@ast
Coronary intervention for persistent occlusion after myocardial infarction
@en
P2093
P2860
P50
P356
P1476
Coronary intervention for persistent occlusion after myocardial infarction
@en
P2093
Aldo P Maggioni
Alice M Mascette
Antonio C Carvalho
Christopher E Buller
Genell L Knatterud
George Sopko
Harvey White
Jamie M Rankin
Jean P Renkin
Jonathan Leor
P2860
P304
P356
10.1056/NEJMOA066139
P407
P577
2006-11-14T00:00:00Z